West pharmaceutical services, inc. introduces novapure® 3ml cartridge components and features smartdose® gen. ii 10ml drug delivery system at pda universe of pre-filled syringes and injection devices

West pharmaceutical services, inc. announced two innovative product offerings at the 2019 pda universe of pre-filled syringes and injection devices (pda pfs). west is launching novapure® 3ml cartridge components, an addition to its novapure product line, comprised of plunger and lined seal components, specifically designed for consistent delivery for higher-volume injectable drug delivery systems. the company also announced that the smartdose® gen. ii 10ml injector, which enables subcutaneous delivery of a wide range of drug formulation viscosities up to 10ml in volume, is now available for commercialization. these innovations, along with highlights from west's high-value product portfolio, integrated solutions program offering, and latest scientific thought leadership, will be showcased at this year's pda pfs meeting, held october 22-23 in gothenburg, sweden. the novapure 3ml cartridge components expand the robust novapure product portfolio which currently includes stoppers and syringe plungers. novapure components embody west's high quality standard for components, adhering to scientific, risk-mitigating quality by design (qbd) principles resulting in dimensional control and consistency, vision inspection and visible particulate control, and best-in class particle specification. the new components are specifically designed for 3ml cartridges often used in autoinjectors and other drug delivery devices. they incorporate west's premium quality enhancements: westar® pharmaceutical wash and sterilization, flurotec® barrier film, and a comprehensive data package, and are an ideal choice for sensitive biologic drugs coming to market. west developed the smartdose portfolio of devices to offer patients with chronic health conditions, who require medication injections, a reliable, convenient and easy-to-use method for home-based drug administration. the smartdose gen. ii 10ml drug delivery system adheres to the patient's body, so patients can remain hands-free during the injection, which may range from minutes to hours. the company has now completed the development work to enable up to 10ml of medication injection and is ready for commercialization.
WST Ratings Summary
WST Quant Ranking